Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

PRIZM and Chiron begin gene therapy collaboration

June 5, 1997

Matrix Pharmaceutical's AccuSite recommended for approval in six European countries

June 4, 1997

Immunomedics' antibody therapy for non-Hodgkin's lymphoma shows promise in clinical trial

June 4, 1997

Banyu developing new anticancer agent

June 4, 1997

RCT issued U.S. patent for azonafide compounds

June 3, 1997

Receptagen receives notice of allowance of U.S. patent for "growth blocker" technology

June 3, 1997

Alpha Therapeutic and Techniclone report milestone in LYM-1 clinical development

June 3, 1997

Schering-Plough's Fareston approved by the FDA

June 3, 1997

Nippon Kayaku discovers new antitumor agent

June 3, 1997

CAAX-based protein farnesyltransferase inhibitors from Merck & Co.

June 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...